Use of compounds of formula (I) where R2, each X, L, Y, Cy, Lp, D and n are as defined in the specification, as serine protease inhibitors.
[EN] SERINE PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE LA SERINE PROTEASE
申请人:PROTHERICS MOLECULAR DESIGN LT
公开号:WO2001044226A1
公开(公告)日:2001-06-21
Compounds of formula (I) where R5, R6a, each X, L, Cy and Lp are as defined in the specification, are tryptase inhibitors useful as antiinflammatory agents.